Health Catalyst (NASDAQ:HCAT) Stock Rating Upgraded by KeyCorp

Health Catalyst (NASDAQ:HCAT) was upgraded by investment analysts at KeyCorp from a “sector weight” rating to an “overweight” rating in a note issued to investors on Wednesday, Marketbeat reports. The firm currently has a $9.00 price objective on the stock. KeyCorp’s price target suggests a potential upside of 22.28% from the company’s previous close.

Other equities analysts have also recently issued research reports about the company. Piper Sandler reiterated an “overweight” rating and set a $12.00 price objective (up previously from $11.00) on shares of Health Catalyst in a report on Tuesday, November 26th. Royal Bank of Canada increased their price objective on shares of Health Catalyst from $8.00 to $9.00 and gave the stock a “sector perform” rating in a research report on Thursday, November 7th. Citigroup boosted their price objective on shares of Health Catalyst from $9.00 to $10.50 and gave the company a “buy” rating in a research report on Wednesday, November 13th. Evercore ISI lifted their price target on Health Catalyst from $8.00 to $10.00 and gave the company an “outperform” rating in a research note on Tuesday, October 8th. Finally, Stephens upped their price objective on Health Catalyst from $7.00 to $9.00 and gave the stock an “equal weight” rating in a research report on Thursday, November 14th. Two research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $11.50.

Health Catalyst Price Performance

Shares of HCAT opened at $7.36 on Wednesday. The stock has a market cap of $447.84 million, a P/E ratio of -5.45 and a beta of 1.36. Health Catalyst has a 1 year low of $5.42 and a 1 year high of $11.41. The stock’s 50-day moving average price is $7.81 and its two-hundred day moving average price is $7.52. The company has a current ratio of 1.41, a quick ratio of 1.41 and a debt-to-equity ratio of 0.32.

Health Catalyst (NASDAQ:HCAT) last released its quarterly earnings data on Wednesday, November 6th. The company reported $0.07 earnings per share for the quarter, missing the consensus estimate of $0.10 by ($0.03). The firm had revenue of $76.40 million for the quarter, compared to the consensus estimate of $76.27 million. Health Catalyst had a negative return on equity of 7.51% and a negative net margin of 26.20%. The firm’s revenue was up 3.5% compared to the same quarter last year. During the same period in the previous year, the business earned ($0.22) EPS. On average, equities analysts predict that Health Catalyst will post -0.33 earnings per share for the current year.

Insider Activity at Health Catalyst

In related news, Director Duncan Gallagher sold 4,500 shares of the company’s stock in a transaction dated Monday, December 23rd. The shares were sold at an average price of $6.98, for a total value of $31,410.00. Following the transaction, the director now owns 74,438 shares in the company, valued at approximately $519,577.24. This represents a 5.70 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Kevin Lee Freeman sold 7,500 shares of the firm’s stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $8.94, for a total transaction of $67,050.00. Following the sale, the insider now owns 236,950 shares of the company’s stock, valued at $2,118,333. This trade represents a 3.07 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 68,342 shares of company stock valued at $554,695. 2.50% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Health Catalyst

Large investors have recently made changes to their positions in the company. Quest Partners LLC acquired a new position in Health Catalyst in the 3rd quarter valued at $34,000. Quarry LP raised its stake in Health Catalyst by 59.4% in the second quarter. Quarry LP now owns 7,002 shares of the company’s stock valued at $45,000 after purchasing an additional 2,610 shares in the last quarter. nVerses Capital LLC bought a new stake in Health Catalyst during the third quarter worth about $59,000. Mackenzie Financial Corp acquired a new position in shares of Health Catalyst in the 2nd quarter valued at approximately $70,000. Finally, Quadrature Capital Ltd bought a new stake in shares of Health Catalyst during the 3rd quarter worth approximately $84,000. Institutional investors own 85.00% of the company’s stock.

Health Catalyst Company Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.